SARS-CoV-2 S1RBD IgG ELISA

Features

• For Research Use Only. Not for diagnostic procedures.
• The total assay time is less than 2.5 hours.
• For the detection and qualitative measurement of IgG class antibodies against the spike protein S1 receptor-binding domain (S1RBD) of SARS-CoV-2 virus in human blood.
• Assay format is 96 wells.
• Components of the kit are provided ready to use or concentrated.

Research topic

COVID-19

Summary

Since December 2019, outbreak of SARS-CoV-2 (COVID-19) infection has become a major epidemic threat in China and brought back the attention of pathogenic coronavirus to the spotlight. Spike protein is an envelopeanchored protein that mediates the recognition and binding of SARS-CoV-2 to host cells. S1 can be further cleaved by the host protease into two subunits called S1 and S2, wherein the S1 polypeptide contain a receptor binding domain (RBD) crucial for the specific recognition and interaction with human receptor ACE2, which is the first and the most essential step for the virus infection. Human anti-SARS-CoV-2 spike protein S1 receptor-binding domain (S1RBD) IgG ELISA kit is a highly sensitive and specific ELISA kit the precision detection and quantitative measurement of titres of anti-S1RBD IgG class antibodies in human serum.